HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiro Ogawa Selected Research

Insulin-Resistant Diabetes Mellitus with Acanthosis Nigricans

12/2017Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiro Ogawa Research Topics

Disease

49Obesity
10/2021 - 01/2002
41Neoplasms (Cancer)
01/2022 - 01/2002
30Hyperaldosteronism (Conn Syndrome)
04/2022 - 12/2015
30Inflammation (Inflammations)
07/2021 - 10/2005
21Insulin Resistance
01/2020 - 01/2002
16Adenoma (Adenomas)
01/2022 - 08/2015
14Type 2 Diabetes Mellitus (MODY)
10/2021 - 09/2003
13Fibrosis (Cirrhosis)
01/2021 - 10/2003
12Body Weight (Weight, Body)
10/2021 - 01/2002
11Hypertension (High Blood Pressure)
01/2022 - 09/2000
11Non-alcoholic Fatty Liver Disease
08/2021 - 11/2011
10Hyperglycemia
03/2021 - 09/2003
10Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2007
8Diabetes Mellitus
02/2022 - 01/2015
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2006
8Hepatocellular Carcinoma (Hepatoma)
01/2021 - 11/2011
8Esophageal Neoplasms (Esophageal Cancer)
04/2010 - 08/2002
7Cushing Syndrome
02/2022 - 05/2014
7Hemorrhage
01/2022 - 01/2002
7Dyslipidemias (Dyslipidemia)
10/2021 - 11/2011
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 11/2009
6Hypertrophy
07/2021 - 09/2000
6Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2021 - 06/2017
6Carcinoma (Carcinomatosis)
01/2020 - 09/2002
6Hypoglycemia (Reactive Hypoglycemia)
01/2020 - 09/2002
5Osteoporosis
06/2021 - 01/2006
5Liver Cirrhosis (Hepatic Cirrhosis)
02/2021 - 01/2015
5Neoplasm Metastasis (Metastasis)
02/2021 - 03/2006
5Hypokalemia
01/2021 - 05/2014
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2005
4Starvation
01/2022 - 03/2010
4Fatty Liver
01/2021 - 11/2011
4Alcoholic Fatty Liver
01/2021 - 01/2015
4Edema (Dropsy)
05/2014 - 03/2003
3Sarcopenia
11/2022 - 01/2017
3Cholangiocarcinoma
01/2022 - 11/2011
3Hypoxia (Hypoxemia)
01/2022 - 06/2021
3Pathologic Constriction (Stenosis)
01/2022 - 12/2018
3Disease Progression
11/2021 - 04/2010
3Albuminuria
11/2021 - 03/2017
3Diabetic Retinopathy (Retinopathy, Diabetic)
11/2021 - 09/2004
3Autoimmune Diseases (Autoimmune Disease)
04/2021 - 04/2003
3Paraganglioma (Paragangliomas)
01/2021 - 03/2017
3Pheochromocytoma
01/2021 - 03/2017
3Gestational Diabetes (Gestational Diabetes Mellitus)
04/2020 - 10/2002
3Lymphoma (Lymphomas)
01/2020 - 04/2006
3Diabetes Complications
01/2020 - 02/2007

Drug/Important Bio-Agent (IBA)

27AldosteroneIBA
01/2022 - 08/2015
26Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2002
18LeptinIBA
08/2017 - 01/2002
15Hydrocortisone (Cortisol)FDA LinkGeneric
04/2022 - 01/2012
14Insulin (Novolin)FDA Link
01/2020 - 01/2002
11Triglycerides (Triacylglycerol)IBA
01/2021 - 04/2003
10Sodium-Glucose Transporter 2 InhibitorsIBA
11/2022 - 01/2016
10EnzymesIBA
03/2022 - 05/2007
10Biomarkers (Surrogate Marker)IBA
11/2021 - 11/2011
9Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
08/2021 - 01/2002
9Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 07/2009
9LipidsIBA
01/2021 - 04/2005
9Adrenocorticotropic Hormone (ACTH)FDA Link
03/2020 - 01/2012
8AdipokinesIBA
01/2019 - 09/2007
8Eicosapentaenoic AcidIBA
01/2015 - 01/2007
7Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2009
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 10/2005
6Messenger RNA (mRNA)IBA
09/2021 - 01/2007
6LigandsIBA
11/2020 - 06/2008
5SodiumIBA
02/2022 - 01/2017
5Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2016
5Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2010
5ReninIBA
01/2022 - 01/2019
5BilirubinIBA
01/2022 - 02/2018
5Hormones (Hormone)IBA
11/2021 - 09/2000
5Sodium-Glucose Transport ProteinsIBA
10/2021 - 01/2019
5CytokinesIBA
09/2021 - 11/2006
5RNA (Ribonucleic Acid)IBA
12/2019 - 11/2002
4Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2022 - 08/2015
4Mineralocorticoid Receptor AntagonistsIBA
01/2022 - 01/2019
4Pharmaceutical PreparationsIBA
08/2021 - 01/2006
4ipragliflozinIBA
07/2021 - 01/2016
4CholesterolIBA
01/2021 - 10/2008
4DNA (Deoxyribonucleic Acid)IBA
01/2018 - 11/2007
4Brain Natriuretic Peptide (Natrecor)FDA Link
12/2007 - 09/2000
3InterleukinsIBA
11/2021 - 01/2015
3CanagliflozinIBA
10/2021 - 01/2018
3GlucocorticoidsIBA
01/2021 - 01/2014
3CatecholaminesIBA
01/2021 - 03/2017
3oxidized low density lipoproteinIBA
11/2020 - 01/2007
3C-Type Lectins (C-Type Lectin)IBA
11/2020 - 09/2014
3MelanocortinsIBA
06/2020 - 01/2002
3Cosyntropin (Cortrosyn)FDA LinkGeneric
03/2020 - 03/2017
3PotassiumIBA
01/2020 - 05/2014
3Streptozocin (Streptozotocin)FDA Link
01/2020 - 03/2013
3Immune Checkpoint InhibitorsIBA
01/2020 - 01/2019
3NivolumabIBA
01/2020 - 06/2018

Therapy/Procedure

28Radiotherapy
07/2012 - 01/2002
24Therapeutics
06/2020 - 01/2002
13Adrenalectomy
01/2022 - 01/2018
9Drug Therapy (Chemotherapy)
01/2022 - 07/2005
4Aftercare (After-Treatment)
08/2020 - 04/2003
3Traction
06/2022 - 01/2020